TransMedics Group, Inc. (TMDX)
NASDAQ: TMDX · Real-Time Price · USD
88.58
-1.06 (-1.18%)
Aug 14, 2026, 4:00 PM EDT - Market closed
TransMedics Group Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 151.7 | 190.29 | 35.46 | -25.03 | -36.23 | -44.22 |
Depreciation & Amortization | 34.02 | 25.89 | 19.76 | 8.18 | 3.48 | 1.82 |
Other Amortization | 2.4 | 1.3 | - | - | - | - |
Loss (Gain) From Sale of Assets | - | 0.08 | 0.02 | - | - | - |
Asset Writedown & Restructuring Costs | - | - | - | 27.21 | - | - |
Loss (Gain) From Sale of Investments | - | - | - | - | 0.49 | 1.36 |
Stock-Based Compensation | 37.09 | 36.86 | 33.22 | 19.79 | 10.32 | 6.88 |
Other Operating Activities | -65.08 | -79.95 | 5.34 | 1.17 | 2.89 | 2.3 |
Change in Accounts Receivable | 0.62 | 13.95 | -34.31 | -33.82 | -21.68 | 0.84 |
Change in Inventory | -23.68 | -7.72 | -8.35 | -28.09 | -8.02 | -4.89 |
Change in Accounts Payable | 3.12 | -0.02 | -1.4 | 6.96 | -3.27 | 5.09 |
Change in Unearned Revenue | 1.56 | 1.14 | -0.2 | 0.08 | - | 0.01 |
Change in Other Net Operating Assets | 4.18 | 11.02 | -0.74 | 10.52 | 6.21 | 1.96 |
Operating Cash Flow | 145.93 | 192.84 | 48.8 | -13.03 | -45.82 | -28.86 |
Operating Cash Flow Growth | 26.59% | 295.14% | - | - | - | - |
Capital Expenditures | -66.89 | -59.25 | -129.74 | -151.85 | -11.91 | -3.52 |
Cash Acquisitions | - | - | 0.44 | -14.89 | - | - |
Sale (Purchase) of Intangibles | - | - | - | -27.21 | - | - |
Investment in Securities | - | - | - | - | 66.42 | 32.79 |
Investing Cash Flow | -66.89 | -59.25 | -129.3 | -193.95 | 54.51 | 29.27 |
Long-Term Debt Issued | - | - | - | 460 | 58.51 | - |
Total Debt Issued | - | - | - | 460 | 58.51 | - |
Long-Term Debt Repaid | - | - | - | -52.07 | -36.05 | - |
Total Debt Repaid | - | - | - | -52.07 | -36.05 | - |
Net Debt Issued (Repaid) | - | - | - | 407.93 | 22.46 | - |
Issuance of Common Stock | 11.79 | 17 | 22.87 | 7.11 | 145.47 | 1.39 |
Repurchase of Common Stock | -0.32 | -0.14 | - | - | - | - |
Other Financing Activities | - | - | - | -14.62 | - | - |
Financing Cash Flow | 11.47 | 16.86 | 22.87 | 400.42 | 167.93 | 1.39 |
Foreign Exchange Rate Adjustments | -0.48 | 1.27 | -0.54 | 0.19 | -1.02 | -0.8 |
Net Cash Flow | 90.04 | 151.72 | -58.16 | 193.63 | 175.6 | 1 |
Free Cash Flow | 79.04 | 133.59 | -80.94 | -164.88 | -57.72 | -32.38 |
Free Cash Flow Growth | 355.51% | - | - | - | - | - |
Free Cash Flow Margin | 11.82% | 22.06% | -18.33% | -68.24% | -61.76% | -107.01% |
Free Cash Flow Per Share | 2.06 | 3.29 | -2.30 | -5.07 | -1.95 | -1.17 |
Levered Free Cash Flow | 44.5 | 94 | -102.77 | -192.83 | -45.96 | -15.66 |
Unlevered Free Cash Flow | 57.77 | 102.62 | -93.76 | -186.09 | -43.64 | -13.24 |
Cash Interest Paid | 10.7 | 10.7 | 11.3 | 8.09 | 3.26 | 3.33 |
Change in Working Capital | -14.21 | 18.38 | -45 | -44.35 | -26.76 | 3 |